Cited by 925TGF-β signaling in diseasesImmune cells in cancerChemokine receptors and signaling

The DOI matches its Crossref record; 60 of the 61 references it cites were found in a registry or an index.

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Open access

Yang, Li, Huang, Jianhua, Ren, Xiubao, Gorska, Agnieszka E., Chytil, Anna, Aakre, Mary, Carbone, David P., Matrisian, Lynn M., Richmond, Ann, Lin, P. Charles, Moses, Harold L.·2008·Cancer Cell

DOI 10.1016/j.ccr.2007.12.004PMC PMC2245859

Open this paper in CoChat — free account Open PDF

Abstract

Aberrant TGFbeta signaling is common in human cancers and contributes to tumor metastasis. Here, we demonstrate that Gr-1+CD11b+ myeloid cells are recruited into mammary carcinomas with type II TGF beta receptor gene (Tgfbr2) deletion and directly promote tumor metastasis. Gr-1+CD11b+ cells infiltrate into the invasive front of tumor tissues and facilitate tumor cell invasion and metastasis through a process involving metalloproteinase activity. This infiltration of Gr-1+CD11b+ cells also results in increased abundance of TGF beta 1 in tumors with Tgfbr2 deletion. The recruitment of Gr-1+CD11b+ cells into tumors with Tgfbr2 deletion involves two chemokine receptor axes, the SDF-1/CXCR4 and CXCL5/CXCR2 axes. Together, these data indicate that Gr-1+CD11b+ cells contribute to TGFbeta-mediated metastasis through enhancing tumor cell invasion and metastasis.

Integrity signals

Registry

Crossref · 10.1016/j.ccr.2007.12.004

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Inflammation and cancer
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J. S., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,677
Endothelial Progenitor Cells
Urbich, C., & Dimmeler, S. (2004) · Circulation Research · doi:10.1161/01.res.0000137877.89448.78 · Cited by 2,388
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Self-citation
Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4
Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., et al. (1999) · Science · doi:10.1126/science.283.5403.845 · Cited by 1,644
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,565
Self-citation
Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,340
Self-citation
A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,264
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Burger, J. A., & Kipps, T. J. (2005) · Blood · doi:10.1182/blood-2005-08-3182 · Cited by 1,197
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian, L. M., Carbone, D. P., & Lin, P. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.031 · Cited by 1,140
Self-citation

Flagged first, then by citations

Show all 61 references

1 of the 61 references couldn’t be matched to a known paper.

Sorted by citations

Items 401–500 of 925

Phosphatase PRL-3 Is a Direct Regulatory Target of TGFβ in Colon Cancer Metastasis
Jiang, Y., Liu, X.-Q., Rajput, A., Geng, L., Ongchin, M. C., Zeng, Q., Taylor, G. S., & Wang, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1487 · Cited by 59
Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA
Paroni, G., Fratelli, M., Gardini, G., Bassano, C., Flora, M., Zanetti, A., Guarnaccia, V., Ubezio, P., Centritto, F., Terao, M., et al. (2011) · Oncogene · doi:10.1038/onc.2011.506 · Cited by 59
The Crosstalk of RAS with the TGF-β Family During Carcinoma Progression and its Implications for Targeted Cancer Therapy
Grusch, M., Petz, M., Metzner, T., Öztürk, D. G., Schneller, D., & Mikulits, W. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910793357943 · Cited by 57
Endometrial hyperplasia-related inflammation: its role in the development and progression of endometrial hyperplasia
Kubyshkin, A. V., Алиев, Л. Л., Фомочкина, И. И., Kovalenko, E. P., Litvinova, S. V., Филоненко, Т. Г., Lomakin, N. V., Kubyshkin, A. V., & Karapetian, O. V. (2016) · Inflammation Research · doi:10.1007/s00011-016-0960-z · Cited by 59
Dysregulated myelopoiesis and hematopoietic function following acute physiologic insult
Loftus, T. J., Mohr, A. M., & Moldawer, L. L. (2017) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000395 · Cited by 58
Revolutionary Cancer Therapy for Personalization and Improved Efficacy: Strategies to Overcome Resistance to Immune Checkpoint Inhibitor Therapy
Almawash, S. (2025) · Cancers · doi:10.3390/cancers17050880 · Cited by 69
Roles of tumor suppressors in regulating tumor-associated inflammation
Yang, L., & Karin, M. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.131 · Cited by 59
Self-citation
Gr-1+CD11b+ myeloid-derived suppressor cells: Formidable partners in tumor metastasis
Yang, L., Edwards, C. M., & Mundy, G. R. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.154 · Cited by 57
Self-citation
Characterization of the first-in-class T-cell-engaging bispecific single-chain antibody for targeted immunotherapy of solid tumors expressing the oncofetal protein claudin 6
Stadler, C., Bähr-Mahmud, H., Plum, L. M., Schmoldt, K., Kölsch, A. C., Türeci, Ö., & Şahin, U. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1091555 · Cited by 58
TGF-² Signaling Pathway in Lung Adenocarcinoma Invasion
Toonkel, R. L., Borczuk, A., & Powell, C. A. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c8cc0c · Cited by 58
Parathyroid Hormone–Related Protein Drives a CD11b+Gr1+ Cell–Mediated Positive Feedback Loop to Support Prostate Cancer Growth
Park, S. I., Lee, C., Sadler, W. D., Koh, A. J., Jones, J., Seo, J. W., Soki, F. N., Cho, S. W., Daignault, S. D., & McCauley, L. K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4692 · Cited by 57
Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis
Shchors, K., Nozawa, H., Xu, J., Rostker, F., Swigart, L. B., Evan, G. I., & Hanahan, D. (2012) · Oncogene · doi:10.1038/onc.2012.60 · Cited by 57
Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis
Jin, K., Pandey, N. B., & Popel, A. S. (2017) · Oncotarget · doi:10.18632/oncotarget.19417 · Cited by 55
The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer
Ganguly, A., Chakraborty, P., Banerjee, K., & Choudhuri, S. K. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.003 · Cited by 57
Immunotherapeutic modulation of the suppressive liver and tumor microenvironments
Chan, T., Wiltrout, R. H., & Weiss, J. M. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.12.024 · Cited by 56
Defective TGF-β Signaling in Bone Marrow–Derived Cells Prevents Hedgehog-Induced Skin Tumors
Fan, Q., Gu, D., Liu, H., Yang, L., Zhang, X., Yöder, M. C., Kaplan, M. H., & Xie, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-2134-t · Cited by 56
Self-citation
Smad3-Deficient CD11b+Gr1+ Myeloid-Derived Suppressor Cells Prevent Allograft Rejection via the Nitric Oxide Pathway
Wu, T., Sun, C., Chen, Z., Yu, Z., Peng, J., Qi, Z., Yang, X., & Zhao, Y. X. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200068 · Cited by 56
Therapeutic applications of the cancer immunoediting hypothesis
Desai, R. R., Coxon, A. T., & Dunn, G. P. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.002 · Cited by 59
Converting “cold” to “hot”: epigenetics strategies to improve immune therapy effect by regulating tumor‐associated immune suppressive cells
Tang, Y., Cui, G., Liu, H., Han, Y., Cai, C., Feng, Z., Shen, H., & Zeng, S. (2024) · 癌症：英文版 · doi:10.1002/cac2.12546 · Cited by 56
Vascular endothelial growth factor plays a critical role in the formation of the pre-metastatic niche via prostaglandin E2
Liu, S., JIANG, M., Zhao, Q., LI, S., Peng, Y., Zhang, P., & Han, M. (2014) · Oncology Reports · doi:10.3892/or.2014.3516 · Cited by 57
Concise Review: Vascular Stem Cells and Tumor Angiogenesis
Melero‐Martin, J. M., & Dudley, A. C. (2010) · Stem Cells · doi:10.1002/stem.583 · Cited by 58
Myeloid-Derived Suppressor Cells Regulate Natural Killer Cell Response to Adenovirus-Mediated Gene Transfer
Zhu, J., Huang, X., & Yang, Y. (2012) · Journal of Virology · doi:10.1128/jvi.01595-12 · Cited by 55
Survival of residual neutrophils and accelerated myelopoiesis limit the efficacy of antibody-mediated depletion of Ly-6G+ cells in tumor-bearing mice
Moses, K., Klein, J. C., Männ, L., Grüneboom, A., Gunzer, M., & Brandau, S. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.1hi0715-289r · Cited by 58
GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
DeNardo, D. G., Galkin, A., Dupont, J., Zhou, L., & Bendell, J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003005 · Cited by 53
Deficiency of Kruppel‐like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid‐derived suppressor cells
Yu, F., Shi, Y. Q., Wang, J., Li, J., Fan, D., & Ai, W. (2013) · International Journal of Cancer · doi:10.1002/ijc.28302 · Cited by 54
The Emerging Role of Immunosurveillance in Dictating Metastatic Spread in Breast Cancer
Slaney, C. Y., Rautela, J., & Parker, B. S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1642 · Cited by 54
Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
Noh, H., Hu, J., Wang, X., Xia, X., Satelli, A., & Li, S. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0093-y · Cited by 59
Prolonged inflammatory microenvironment is crucial for pro-neoplastic growth and genome instability: a detailed review
Anuja, K., Roy, S., Ghosh, C., Gupta, P., Bhattacharjee, S., & Banerjee, B. (2016) · Inflammation Research · doi:10.1007/s00011-016-0985-3 · Cited by 57
Stroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung Cancer
Zhu, Y. J., Zhang, L., Zha, H., Yang, F., Hu, C., Chen, L., Guo, B., & Zhu, B. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19398 · Cited by 54
Immune Checkpoint Inhibitors in the Treatment of Melanoma: From Basic Science to Clinical Application
Surface Oncology, 5. H. S., Rausch, M. P., & Hastings, K. T. (2017) · Codon Publications eBooks · doi:10.15586/codon.cutaneousmelanoma.2017.ch9 · Cited by 56
Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model
Biswas, T., Gu, X., Yang, J., Ellies, L. G., & Sun, L.-Z. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.018 · Cited by 52
“TGF-b is an important modulator of the immune system, particularly as a regulator of T-cells and myeloid cells [28,29].”
Myeloid-derived suppressor cell impact on endogenous and adoptively transferred T cells
Arina, A., & Bronte, V. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.006 · Cited by 53
Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer
Osmulski, P. A., Cunsolo, A., Chen, M., Qian, Y., Lin, C.-L., Hung, C., Mahalingam, D., Kirma, N. B., Chen, C., Taverna, J. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3595 · Cited by 53
The characteristics of the tumor immune microenvironment in colorectal cancer with different MSI status and current therapeutic strategies
Wang, Q., Yu, M., & Zhang, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1440830 · Cited by 56
MDSC and TGFβ Are Required for Facilitation of Tumor Growth in the Lungs of Mice Exposed to Carbon Nanotubes
Shvedova, A. A., Kisin, E. R., Yanamala, N. V. K., Tkach, A. V., Gutkin, D. W., Star, A., Shurin, G. V., Kagan, V. E., & Shurin, M. R. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2376 · Cited by 53
Microenvironment and tumor progression of melanoma: New therapeutic prospectives
Botti, G., Cerrone, M., Scognamiglio, G., Anniciello, A., Ascierto, P. A., & Cantile, M. (2012) · Journal of Immunotoxicology · doi:10.3109/1547691x.2012.723767 · Cited by 53
Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma
Xu, Y., Fang, F., Jiao, H., Zheng, X., Huang, L., Yi, X., & Zhao, W. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-019-02414-9 · Cited by 53
Modification of the Tumor Microenvironment as a Novel Target of Renal Cell Carcinoma Therapeutics
Finke, J. H., Rayman, P. A., Ko, J. S., Bradley, J. M., Gendler, S. J., & Cohen, P. A. (2013) · The Cancer Journal · doi:10.1097/ppo.0b013e31829da0ae · Cited by 52
Id1 enhances human ovarian cancer endothelial progenitor cell angiogenesis via PI3K/Akt and NF-κB/MMP-2 signaling pathways
Su, Y., Gao, L.-J., Teng, L. L., Wang, Y., Cui, J., Peng, S., & Fu, S. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-132 · Cited by 53
The Role of Myeloid-Derived Suppressor Cells in Viral Infection
O’Connor, M. A., Rastad, J. L., & Green, W. R. (2017) · Viral Immunology · doi:10.1089/vim.2016.0125 · Cited by 51
Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer
Lecavalier‐Barsoum, M., Chaudary, N., Han, K. C.-Z., Koritzinsky, M., Hill, R. P., & Milosevic, M. (2018) · International Journal of Cancer · doi:10.1002/ijc.31297 · Cited by 53
Tolerance and immune suppression in the tumor microenvironment
Ostrand‐Rosenberg, S. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.09.011 · Cited by 51
Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
Ahluwalia, M. S., & Gladson, C. L. (2010) · Journal of Oncology · doi:10.1155/2010/689018 · Cited by 55
Signaling from membrane receptors to tumor suppressor WW domain-containing oxidoreductase
Chang, J.-Y., He, R., Lin, H., Hsu, L., Lai, F., Hong, Q., Chen, S.-J., & Chang, N. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.009351 · Cited by 51
In VitroandIn VivoAnticancer Effects of Sterol Fraction from Red AlgaePorphyra dentata
Kazłowska, K., Lin, H. V., Chang, S., & Tsai, G. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/493869 · Cited by 51
Immunotherapy for lung cancer: advances and prospects.
Li, Y., Wang, L., & Zhang, Y. (2016) · PubMed Central · Cited by 51
Mesenchymal stem cells promote endothelial progenitor cell migration, vascularization, and bone repair in tissue‐engineered constructs via activating CXCR2‐Src‐PKL/Vav2‐Rac1
Li, Z., Yang, A., Yin, X., Dong, S., Luo, F., Dou, C., Lan, X., Xie, Z., Hou, T., Xu, J., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700895r · Cited by 51
Inhibition of CCL7 derived from Mo-MDSCs prevents metastatic progression from latency in colorectal cancer
Ren, X., Xiao, J., Zhang, W., Wang, F., YongRong, Y., Wu, X., Zeng, Z., He, Y., Yang, W., Liao, W., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03698-5 · Cited by 50
Self-citation
CD40 controls CXCR5-induced recruitment of myeloid-derived suppressor cells to gastric cancer
Ding, Y., Shen, J., Zhang, G., Chen, X., Wu, J., & Chen, W. (2015) · Oncotarget · doi:10.18632/oncotarget.5644 · Cited by 50
Surgery-induced monocytic myeloid-derived suppressor cells expand regulatory T cells in lung cancer
Wang, J., Liu, Y., Yu, L., Wang, Y.-Y., Chen, R., Qian, J., Hong, Z., & Su, X. (2017) · Oncotarget · doi:10.18632/oncotarget.14991 · Cited by 49
Cdx Genes, Inflammation, and the Pathogenesis of Intestinal Metaplasia
Stairs, D. B., Kong, J., & Lynch, J. P. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-381280-3.00010-5 · Cited by 49
New insights into myeloid-derived suppressor cells and their roles in feto-maternal immune cross-talk
Zhao, A., Xu, H., Kang, X., Zhao, A., & Lu, L. (2015) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2015.11.001 · Cited by 49
Leukocytes as paracrine regulators of metastasis and determinants of organ‐specific colonization
Erez, N., & Coussens, L. M. (2011) · International Journal of Cancer · doi:10.1002/ijc.26032 · Cited by 49
Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: How to break a vicious cycle
Würdinger, T., Deumelandt, K., van der Vliet, H. J., Wesseling, P., & de Gruijl, T. D. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.10.003 · Cited by 50
Reflections on the Spread of Metastasis to Cancer Prevention
Taketo, M. M. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0046 · Cited by 48
Tumor-Derived Transforming Growth Factor-β is Critical for Tumor Progression and Evasion from Immune Surveillance
Li, Z., Zhang, L., Zhang, H.-R., Tian, G., Tian, J., Mao, X., Jia, Z., Meng, Z., Zhao, L., Yin, Z., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.13.5181 · Cited by 48
The epigenetic hallmarks of immune cells in cancer
Yu, J. H., Xiao, C., Fan, T. T., Deng, Z., Wang, D., Cai, W., Li, J., Liao, T., Li, C., & He, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02255-4 · Cited by 52
Strategies to Use Immune Modulators in Therapeutic Vaccines Against Cancer
Berzofsky, J. A., Terabe, M., & Wood, L. V. (2012) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.02.002 · Cited by 48
Immunomodulatory Function of Myeloid-Derived Suppressor Cells during B Cell-Mediated Immune Responses
Stoll, B., Lim, H., & Park, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051468 · Cited by 47
TGF-beta: a master switch in tumor immunity
Gigante, M., Gesualdo, L., & Ranieri, E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802430378 · Cited by 45
Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells
Moura, T., Laranjeira, P., Caramelo, O. L., Gil, A. M., & Paiva, A. A. (2025) · Current Oncology · doi:10.3390/curroncol32030143 · Cited by 56
Parathyroid Hormone–Related Protein Protects against Mammary Tumor Emergence and Is Associated with Monocyte Infiltration in Ductal Carcinoma In situ
Fleming, N. I., Trivett, M. K., George, J., Slavin, J., Murray, W. K., Moseley, J. M., Anderson, R. L., & Thomas, D. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0194 · Cited by 46
Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model
Zhang, K.-Z., Zhang, Q., Zhang, Q., Sun, H., Ao, J., Chai, Z., Zhu, X., Lu, L., Zhang, Y., Bu, Y., et al. (2014) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-7-28 · Cited by 46
Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond
Khoshbin, A. P., Eskian, M., Keshavarz‐Fathi, M., & Rezaei, N. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0531-9 · Cited by 46
LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex
Duvall-Noelle, N., Karwandyar, A., Richmond, A. J., & Raman, D. (2015) · Oncogene · doi:10.1038/onc.2015.166 · Cited by 46
Self-citation
Cancer and bone: A complex complex
van Driel, M., & van Leeuwen, J. P. T. M. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.013 · Cited by 46
The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis
Chen, B., Mu, C., Zhang, Z., He, X., & Liu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.891268 · Cited by 48
Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking
Younos, I., Dafferner, A. J., Gülen, D., Britton, H. C., & Talmadge, J. E. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.05.002 · Cited by 46
Tranilast Inhibits the Function of Cancer‐Associated Fibroblasts Responsible for the Induction of Immune Suppressor Cell Types
Ohshio, Y., Hanaoka, J., Kontani, K., & Teramoto, K. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12242 · Cited by 46
The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesis
Yi, H., Geng, L., Black, A. R., Talmon, G. A., Berim, L. D., & Wang, J. (2017) · Oncogene · doi:10.1038/onc.2016.499 · Cited by 47
Myeloid‐derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells
Ren, J., Zeng, W., Tian, F., Zhang, S., Wu, F., Qin, X., Zhang, Y., & Lin, Y. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13099 · Cited by 45
Resisting Resistance to Immune Checkpoint Therapy: A Systematic Review
Haibe, Y., Husseini, Z. E., Sayed, R. E., & Shamseddine, A. I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176176 · Cited by 45
Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy
Takacs, G. P., Flores‐Toro, J., & Harrison, J. K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107790 · Cited by 47
CXCR2-Dependent Endothelial Progenitor Cell Mobilization in Pancreatic Cancer Growth
Li, A., Cheng, X. J., Moro, A., Singh, R. K., Hines, O. J., & Eibl, G. (2011) · Translational Oncology · doi:10.1593/tlo.10184 · Cited by 45
Proactive and reactive roles of TGF-β in cancer
Kuburich, N. A., Sabapathy, T., Demestichas, B. R., Maddela, J. J., den Hollander, P., & Mani, S. A. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.08.002 · Cited by 43
Efferocytosis Creates a Tumor Microenvironment Supportive of Tumor Survival and Metastasis
(2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.666 · Cited by 44
Platelet factor 4 is produced by subsets of myeloid cells in premetastatic lung and inhibits tumor metastasis
Jiang, J., Pang, Y., Yan, H. H., Min, Y., Achyut, B. R., Hollander, M. C., Lin, P. C., Liang, X., & Li, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.9486 · Cited by 45
Self-citation
Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs
Mackert, J. R., Qu, P., Min, Y., Johnson, P. F., Li, Y., & Lin, P. C. (2017) · Scientific Reports · doi:10.1038/s41598-017-12968-2 · Cited by 44
Self-citation
Host Cxcr2-dependent regulation of mammary tumor growth and metastasis
Sharma, B., Nannuru, K. C., Varney, M. L., & Singh, R. K. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9691-0 · Cited by 45
Roles of Myeloid-Derived Suppressor Cell Subpopulations in Autoimmune Arthritis
Li, M., Zhu, D., Wang, T., Xia, X., Tian, J., & Wang, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02849 · Cited by 43
Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
Dong, Y., Wan, Z., Gao, X., Yang, G., & Liu, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.609762 · Cited by 45
Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma
Kondo, Y., Suzuki, S., Takahara, T., Ono, S., Goto, M., Miyabe, S., Sugita, Y., Ogawa, T., Ito, H., Satou, A., et al. (2021) · Cancer Science · doi:10.1111/cas.15081 · Cited by 43
Modulating the Expression of IFN Regulatory Factor 8 Alters the Protumorigenic Behavior of CD11b+Gr-1+ Myeloid Cells
Stewart, T. J., Liewehr, D. J., Steinberg, S. M., Greeneltch, K. M., & Abrams, S. I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804132 · Cited by 43
Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
Giallongo, C., Parrinello, N. L., Brundo, M. V., Raccuia, S. A., Rosa, M. D., Cava, P. L., & Tibullo, D. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00107 · Cited by 42
Myeloid cell diversification and complexity: an old concept with new turns in oncology
Chioda, M., Peranzoni, E., Desantis, G., Papalini, F., Falisi, E., Solito, S., Mandruzzato, S., & Bronte, V. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9268-1 · Cited by 42
Context-dependent roles for lymphotoxin-β receptor signaling in cancer development
Fernandes, M. T., Dejardin, E., & dos Santos, N. R. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.02.005 · Cited by 44
Neutrophils: Critical components in experimental animal models of cancer
Hagerling, C., & Werb, Z. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.02.003 · Cited by 43
Multi‐omics analysis identifies pathways and genes involved in diffuse‐type gastric carcinogenesis induced by E‐cadherin, p53, and Smad4 loss in mice
Park, J. W., Kim, M., Voon, D. C., Kim, S., Bae, J., Mun, D., Ko, S.-I., Kim, H. K., Lee, S., & Kim, D.-Y. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22803 · Cited by 41
Characterization of iNOS+ Neutrophil-like ring cell in tumor-bearing mice
Virtuoso, L. P., Harden, J. L., Sotomayor, P. C., Sigurdson, W. J., Yoshimura, F., Egilmez, N. K., Minev, B., & Kilinc, M. O. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-152 · Cited by 41
Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours
White, L. G., Goy, H. E., Rose, A. J., & McLellan, A. D. (2022) · Cancers · doi:10.3390/cancers14040978 · Cited by 41
Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function
Zhang, H., Li, Z., Wang, L., Tian, G., Tian, J., Yang, Z., Cao, G., Zhou, H. Y., Zhao, L., Wu, Z., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00129 · Cited by 40
Myeloid-derived suppressor cell and macrophage exert distinct angiogenic and immunosuppressive effects in breast cancer
Fang, Z., Wen, C., Chen, X., Yin, R., Zhang, C., Wang, X., & Huang, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.17013 · Cited by 44
Lactoferrin deficiency induces a pro-metastatic tumor microenvironment through recruiting myeloid-derived suppressor cells in mice
Wei, L., Zhang, X., Wang, J., Ye, Q., Zheng, X., Qiu, P., Zheng, Y., Liu, P., Zhang, X., Li, Z., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0970-8 · Cited by 40
Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice
Gorczynski, R. M., Clark, D. A., Erin, N., & Khatri, I. A. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1259-3 · Cited by 40
Characterization of the MDSC Proteome Associated with Metastatic Murine Mammary Tumors Using Label-Free Mass Spectrometry and Shotgun Proteomics
Boutté, A. M., McDonald, W. H., Shyr, Y., Li, Y., & Lin, P. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022446 · Cited by 41
Self-citation
Roles of Bone Marrow Cells in Skeletal Metastases: No Longer Bystanders
Park, S. I., Soki, F. N., & McCauley, L. K. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0081-8 · Cited by 39
Negative Regulation of Myeloid-derived Suppressor Cells in Cancer
Qu, P., Boelte, K. C., & Lin, P. C. (2012) · Immunological Investigations · doi:10.3109/08820139.2012.685538 · Cited by 39
Self-citation
IL-13 signaling via IL-13Rα2 triggers TGF-β1-dependent allograft fibrosis
Brunner, S. M., Schiechl, G., Kesselring, R., Martin, M. P., Balam, S., Schlitt, H. J., Geissler, E. K., & Fichtner‐Feigl, S. (2013) · Transplantation Research · doi:10.1186/2047-1440-2-16 · Cited by 39
Pro-apoptotic Bim suppresses breast tumor cell metastasis and is a target gene of SNAI2
Mérino, D., Best, S. A., Asselin-Labat, M.-L., Vaillant, F., Pal, B., Dickins, R. A., Anderson, R. L., Strasser, A., Bouillet, P., Lindeman, G. J., et al. (2014) · Oncogene · doi:10.1038/onc.2014.313 · Cited by 39
Influence of bone marrow-derived hematopoietic cells on the tumor response to radiotherapy: Experimental models and clinical perspectives
Ahn, G., & Brown, J. M. (2009) · Cell Cycle · doi:10.4161/cc.8.7.8075 · Cited by 39

Authors: Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., & Moses, H. L.
Affiliations: Vanderbilt University (US)
Corresponding author: Moses, Harold L.
ORCID: Huang, Jianhua
Ren, Xiubao
Gorska, Agnieszka E.
Carbone, David P.
Matrisian, Lynn M.
Richmond, Ann
Moses, Harold L.
Venue: Cancer Cell
Publisher: Elsevier BV
Published: 2008-01
Volume: 13
Issue: 1
Pages: 23-35
ISSN: 1535-6108 (ISSN-L)
DOI: 10.1016/j.ccr.2007.12.004
PMC: PMC2245859
OpenAlex: W2130870648
Cited by: 918
References: 61
Citations by year: 2026: 10 · 2025: 19 · 2024: 30 · 2023: 25 · 2022: 41 · 2021: 58 · 2020: 41 · 2019: 52 · 2018: 42 · 2017: 47 · 2016: 62 · 2015: 59 · 2014: 64 · 2013: 78 · 2012: 77
FWCI: 29.18
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2024 d)
Locations: Cancer Cell (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs (IK6 BX005225)
Vanderbilt University
National Cancer Institute (CA068485, CA 085492, R01CA085492, R01CA116021, CA102162, R01CA108856, CA126505, R01CA076321, R01CA034590, P50CA098131, R01CA102162, CA108856, P30CA068485, U54CA126505)
National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK58404, P30DK058404)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Keywords: TGF-beta signaling, breast cancer, tumor-associated macrophages, metastasis, tumor invasion, metalloproteinase activity, SDF-1/CXCR4 axis, chemokine receptors, myeloid cell recruitment
MeSH terms: Receptor, Transforming Growth Factor-beta Type II, Animals, Breast Neoplasms, Female, Humans, Models, Biological, Neoplasm Invasiveness, Neoplasm Metastasis, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Matrix Metalloproteinases, Myeloid Cells, CD11b Antigen, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks